Cullinan Oncology, Inc.

NASDAQ

CGEM

Stock

Yield per half year: -15%
Dividend yield: 0%
Sector: Healthcare

Compare companies

Download the report:

Excel

Word

PDF

	Cullinan Oncology, Inc.	Gilead Sciences	Amgen
Capitalization
Price	8.67	109.64	295.27
Price priv.
Number of shares, million	53.77	1255	541
Capitalization, billion	0.4479	94.55	140.05
EBITDA, billion	-0.1672	4.43	13.36
EV, billion	0.5741	132.19	189.13
Profit and loss report
Net profit, billion	-0.1674	0.48	4.09
Revenue, billion	0.0189	28.75	33.42
EPS	-3.11	0.3825	7.56
Balance
Assets, billion	0.6218	59	91.84
Debt, billion	0.0022	26.71	60.1
Balance cost, billion	0.5903	19.33	5.88
Cash, billion	0.083	9.99	11.97
Coefficients
Dividend yield, %	0	3.17	2.94
Dividend	0	3.12	9.26
Dividend yield priv., %	0	0	0
Dividend priv.	0	0	0
Dividends/profit, %	0	816.25	118.14
P/S	20.06	4.02	4.22
P/BV	1.11	6	23.99
P/E	4.08	240.57	34.48
Ev/Ebitda	-3.43	29.81	14.16
Debt/Ebitda	-0.0129	6.02	4.5
Efficiency
ROE	-32.06	2.28	67.55
ROA	-30.27	0.7926	4.33
ROIC	-17.58	11.06	17
Ebitda margin	-884.4	15.42	39.96
Net margin	-358.7	1.67	12.24
Momentum
1 week, price changes	-4.52 %	-3.4 %	-0.3905 %
1 month, price changes	+9.89 %	-2.16 %	+6.76 %
3 months, price changes	+11.3 %	+7.91 %	+8.9 %
6 months, price changes	-15 %	-5.01 %	-5.32 %
1 year, price changes	-54.03 %	+26.17 %	-8.99 %
3 years, price changes	-31.62 %	+52.51 %	+11.33 %
5 years, price changes		+61.93 %	+15.95 %
10 years, price changes		+49.45 %	+91.29 %

More data >>

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

Subscribe